KRS Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$201K	Hold	260	–	–	0.12%	115
2025 Q4	$201K	Buy	+260	New	+$177K	0.12%	115
2025 Q2	–	Sell	-330	Closed	-$209K	–	110
2025 Q1	$209K	Hold	330	–	–	0.17%	100
2024 Q4	$235K	Hold	330	–	–	0.17%	103
2024 Q3	$347K	Hold	330	–	–	0.25%	75
2024 Q2	$347K	Hold	330	–	–	0.26%	81
2024 Q1	$318K	Hold	330	–	–	0.26%	88
2023 Q4	$290K	Hold	330	–	–	0.27%	88
2023 Q3	$272K	Sell	330 -15	-4%	-$11.8K	0.29%	86
2023 Q2	$248K	Hold	345	–	–	0.25%	95
2023 Q1	$283K	Sell	345 -10	-3%	-$7.54K	0.32%	87
2022 Q4	$256K	Buy	355 +40	+13%	+$29.5K	0.35%	89
2022 Q3	$216K	Buy	+315	New	+$198K	0.3%	91
2022 Q2	–	Sell	-315	Closed	-$220K	–	108
2022 Q1	$220K	Hold	315	–	–	0.24%	108
2021 Q4	$198K	Buy	+315	New	+$194K	0.17%	118